Skip to main content

CMGIC23011 // NRG-GI008 // McGreevy

Basic Study Information

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.

Location: University of Rochester

Lead Researcher (Principal Investigator)

Lead Researcher:  Maria McGreevy

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email:

Additional Study Details

Return to Search